Citius Pharmaceuticals is trading at $0.47 (-5.16%) following a weak market open and continued intraday selling pressure.
- There is no credible company-specific news or fundamental catalyst available to explain the current downward move.
- The stock is notably lagging the broader market, with the Nasdaq up 0.84% and the S&P 500 up 0.40%, indicating the decline is not part of a general risk-off trend.